A detailed history of Driehaus Capital Management LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Driehaus Capital Management LLC holds 846,171 shares of ADPT stock, worth $6.34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
846,171
Previous 435,294 94.39%
Holding current value
$6.34 Million
Previous $2.23 Million 127.87%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.37 - $6.78 $1.8 Million - $2.79 Million
410,877 Added 94.39%
846,171 $5.08 Million
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $1.47 Million - $2.23 Million
435,294 New
435,294 $2.23 Million
Q3 2019

Nov 14, 2019

SELL
$30.31 - $53.51 $1.41 Million - $2.49 Million
-46,490 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$40.3 - $48.3 $1.87 Million - $2.25 Million
46,490 New
46,490 $2.25 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.07B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.